Amanta Healthcar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
120.75
0.00 (0.00%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 1.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039743,
    "name": "Amanta Healthcar",
    "stock_name": "Amanta Healthcar",
    "full_name": "Amanta Healthcare Ltd",
    "name_url": "stocks-analysis/amanta-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "120.75",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "120.75",
    "mcapval": "464.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544502,
    "symbol": "AMANTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE084K01015",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "09:06 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "1.17 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amanta-healthcar-10039743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Amanta Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-4017868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_mojoScore_4017868.png",
        "date": "2026-05-28 10:10:44",
        "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Amanta Healthcare’s Volatile Week: 0.58% Dip Amid Margin Pressures and Mixed Market Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcares-volatile-week-058-dip-amid-margin-pressures-and-mixed-market-moves-4007648",
        "imagepath": "",
        "date": "2026-05-23 09:03:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at Rs.124.40, declines 4.16%</p>\n                    <p><strong>19 May:</strong> Sharp rebound of 7.15% post Q4 FY26 results announcement</p>\n                    <p><strong>20 May:</strong> Stock retreats 5.25% amid margin pressure concerns</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.129.05, down 0.58% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.124.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.129.05</div..."
      },
      {
        "title": "Are Amanta Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-amanta-healthcare-ltd-latest-results-good-or-bad-4001527",
        "imagepath": "",
        "date": "2026-05-20 19:26:00",
        "description": "Amanta Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹76.99 crores, marking a sequential increase of 3.36% from the previous quarter and a year-on-year growth of 6.84%. This indicates some positive momentum in revenue generation, potentially suggesting improved market penetration or product portfolio expansion.\n\nHowever, the operational efficiency metrics reveal challenges. The net profit for the quarter rose to ₹5.53 crores, a 19.44% increase from Q3 FY26, driven by lower interest costs and a slight uptick in other income. Despite this, the net profit remains below the previous year's figure, highlighting ongoing profitability concerns. The operating margin contracted to 19.42%, down from 20.62% in the prior quarter, indicating significant cost pressures or pricing challenges that may affect the company's ability to maintain..."
      },
      {
        "title": "Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-ltd-reports-flat-quarterly-performance-amid-margin-pressure-4000008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_fintrenddot_4000008.png",
        "date": "2026-05-20 08:00:24",
        "description": "Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record net sales and a strong operating profit to interest ratio, the company’s operating profit margin contracted significantly, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Amanta Healthcare Q4 FY26: Margin Pressures Overshadow Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/amanta-healthcare-q4-fy26-margin-pressures-overshadow-revenue-growth-3999906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_quaterlyResult_3999906.png",
        "date": "2026-05-19 22:17:47",
        "description": "Amanta Healthcare Limited, a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹493.00 crores, reported a mixed performance for Q4 FY26 (January-March 2026), with net profit rising to ₹5.53 crores from ₹4.63 crores in the previous quarter, marking a sequential growth of 19.44%. However, the quarter revealed concerning margin compression, with operating profit margins declining to 19.42% from 20.62% in Q3 FY26, whilst the stock surged 7.15% to ₹133.30 following the results announcement."
      },
      {
        "title": "Amanta Healthcare Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-hold-3995329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_mojoScore_3995329.png",
        "date": "2026-05-17 10:10:27",
        "description": "Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Amanta Healthcare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-amanta-healthcare-ltd-3988254",
        "imagepath": "",
        "date": "2026-05-12 23:18:01",
        "description": "The next results date for Amanta Healthcare Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Amanta Healthcare Ltd Falls 1.85%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-ltd-falls-185-3-key-factors-driving-the-weekly-decline-3982587",
        "imagepath": "",
        "date": "2026-05-09 09:01:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 4:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>May 5:</strong> Technical momentum shifts to mildly bullish with strong price gains</p>\n                    <p><strong>May 6:</strong> MarketsMOJO upgrades rating to Hold following financial improvements</p>\n                    <p><strong>May 8:</strong> Week closes at Rs.137.70, down 1.85%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.140.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"sta..."
      },
      {
        "title": "Amanta Healthcare Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-upgraded-to-hold-by-marketsmojo-amid-technical-and-financial-improvements-3977194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AmantaHealthcar_mojoScore_3977194.png",
        "date": "2026-05-06 08:38:49",
        "description": "Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 5 May 2026, is driven by a combination of enhanced technical trends, robust quarterly financial results, attractive valuation metrics, and increased institutional participation, despite some lingering concerns over long-term fundamentals and debt servicing capacity."
      }
    ],
    "total": 36,
    "sid": "10039743",
    "stock_news_url": "https://www.marketsmojo.com/news/amanta-healthcare-10039743"
  },
  "announcements": [
    {
      "caption": "Intimation For Commissioning Of Solar Power Plant For Captive Consumption",
      "datetime": "30-May-2026",
      "details": "Intimation for commissioning of solar power plant for captive consumption",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In Utilization Of Funds If Any.",
      "datetime": "29-May-2026",
      "details": "statement of deviation or variation of funds if any",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Amanta Healthcare’s Volatile Week: 0.58% Dip Amid Margin Pressures and Mixed Market Moves

2026-05-23 09:03:22

Key Events This Week

18 May: Stock opens at Rs.124.40, declines 4.16%

19 May: Sharp rebound of 7.15% post Q4 FY26 results announcement

20 May: Stock retreats 5.25% amid margin pressure concerns

22 May: Week closes at Rs.129.05, down 0.58% for the week

stock-recommendationAnnouncement

Intimation For Commissioning Of Solar Power Plant For Captive Consumption

30-May-2026 | Source : BSE

Intimation for commissioning of solar power plant for captive consumption

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026

Statement Of Deviation Or Variation In Utilization Of Funds If Any.

29-May-2026 | Source : BSE

statement of deviation or variation of funds if any

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available